Biologically Active Substances From The Genus Scrophularia
Biologically Active Substances From The Genus Scrophularia
Biologically Active Substances From The Genus Scrophularia
To cite this article: J. de Santos Galíndez, A.M.a Díaz Lanza & L. Fernández Matellano (2002)
Biologically Active Substances from the Genus Scrophularia, Pharmaceutical Biology, 40:1, 45-59,
DOI: 10.1076/phbi.40.1.45.5864
Review
Department of Pharmacology, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, Madrid, Spain
ANTIINFLAMMATORY (Giner et al., (Garcia et al., (Kajimoto et al., (Bermejo (Paris & Moyse,
1991, 2000; 1996; 1989; Quian Benito et 1976;
Cuellar et Fernandez et et al., 1991, al., 1998, Schaunbenger
al., 1998) al., 1996, 1992; Zhang 2000) & Paris,
1998) et al., 1194) 1977;
ANTIBACTERIAL (Swiatek, 1970, (Fernandez et Vigneau,
1973; Paris & al., 1996) 1985) (Paris
Moyse, 1976; & Moyse,
Van Hellemont, 1976;
1986) Schaunbenger
& Paris,
1977;
Rombouts and
Links, 1956;
Swiatek,
1970)
(Swiatek, 1970)
HEPATOPROTECTIVE
IMMUNOMODULATOR
(Kajimoto et al., (Karimova et
CARDIOVASCULAR 1989; Ody, al., 1966)
1993)
(Fernandez (Akhmedov et
DIURETIC Arche et al., 1969;
al., 1993) Schaunbenger
& Paris,
1977)
(Martin et al.,
PROTOZOOCIDAL 1998;
FUNGICIDAL AND Emam et
MOLLUSCICIDAL al., 1997)
(Garcia et al., (Miyazawa et
ANTITUMOR CYTOTOXIC 1998) al., 1998;
AND CYTOSTATIC Pinkas et al.,
1994; Liu &
Wu, 1993)
NEUROPROTECTIVE
(Tohda et al.,
ANTIPRURITIC 2000)
(Karimova et
OTHERS al., 1996)
verbascoside (8), angoroside A (9) and angoroside C (10) and 6-O-a-L-(4≤-O-acetyl 2≤,3≤-O-di-p-methoxycin-
(Kajimoto et al., 1989; Zhang et al., 1994; Qian et al., 1992). namoyl)-rhamnopyranosyl-catalpol (12)], isolated from S.
Pharmacological investigations are necessary for evaluating auriculata L., exert high antiinflammatory activity on mouse
their potential as antiinflammatory agents. ear edema induced by tetradecanoylphorbol acetate (TPA).
S. auriculata is a medicinal plant used in traditional med- When these products were assayed at the same dose as
icine against inflammatory skin diseases. Its aqueous alcohol indomethacin (0.5 mg/ear), they exhibited nearly the same
extract showed a marked effect on both acute and chronic effect as this reference drug with an edema percentage inhi-
models of inflammation (Cúellar et al., 1998). bition of 73.4% (Giner et al., 1991).
Two catalpol derivates [6-O-a-L-(2≤-O-acetyl-3≤,4≤-O- Two saponins, verbascosaponin A (13) and verbascos-
di-p-methoxycinnamoyl-rhamnopyranosyl)-catalpol (11) aponin (14), and two iridoids, scropolioside A (15) and
Biologically active substances from Scrophularia 47
Table 1 (continued)
(Won Sick
Woo,
1963)
(Saracoglu
et al.,
1997)
(Bhandari
et al.,
1992)
scrovalentinoside (16), isolated from S. auriculata ssp. corticoids. When the putative corticoid-like mechanism of
pseudoauriculata, assayed with various acute and chronic the two compounds was studied, verbascosaponin A (13)
experimental models, showed antiinflammatory activity activity was notably reduced by the mRNA synthesis
against all the inducers with the exception of arachidonic inhibitor, actinomycin D, while the effect of scropolioside A
acid (Giner et al., 2000). Both saponins significantly inhib- (15) was partially blocked by the anti-glucocorticoid drugs
ited mouse paw edema induced by single and multiple doses used. Both iridoids were active on the delayed-type hyper-
of 12-O-tetradecanoylphorbol 13-acetate (TPA). Verbascos- sensitivity reaction. They significantly reduced the inflam-
aponin A (13) showed a potency twice as high as that of matory lesion and suppressed cellular infiltration.
indomethacin in the acute TPA model. Verbascosaponin A The aqueous extract and harpagoside (2) isolated from S.
(13) and scropolioside A (15) were active after a long latency frutescens L. were tested for antiinflammatory activity on rat
period against ethyl phenylpropiolate edema, as are gluco- paw edema. The results obtained showed that the aqueous
48 J. de Santos Galíndez et al.
Table 2. Bioactive compounds, parts or fractions and activities derived from Scrophularia species.
S. auriculata Plant, phenolic acids (antibacterial) (Swiatek, 1970, 1973; Paris & Moyse, 1976;
Van Hellemont, 1986)
(11–16) Iridoids and saponins (antiinflammatory), (Giner et al., 1991, 2000; Cuellar et al., 1998)
Plant, hidroalcoholic extract
S. buergeriana (17–19, 33, 38, 41–45) Chloroform methanol extract (Kim & Kim, 2000)
from roots, phenylpropanoids (neuroprotective)
S. canina Plant, phenolic acids (antibacterial) (Swiatek, 1970, 1973; Paris & Moyse, 1976;
Van Hellemont, 1986)
S. frutescens (2, 17–23) Aqueous extract, phenolic acids, iridoid (Garcia et al., 1996; Fernandez et al., 1996,
(antiinflammatory) 1998)
Aqueous extract of the aerial parts (ashes), (Fernandez Arche et al., 1993)
flavonoids and saponins (diuretic)
(17–23) Phenolic acids (antitumor, cytotoxic and (Garcia et al., 1998)
cytostatic)
(17–23, 31, 32) Aerial part, phenolic acids (Fernandez et al., 1996)
(antibacterial)
S. grossheimi Plant (diuretic) (Akhmedov et al., 1969; Schaunbenger &
Paris, 1977)
(36) Extract, flavonoids (cardiovascular) (Akhmedov et al., 1969)
Flavonoid fraction (hepatoprotective) (Akhmedov et al., 1969)
S. koelzii (2, 15, 34, 35) Alcoholic extract, chloroform fraction (Garg et al., 1994)
from alcoholic extract of the aerial parts, iridoids
(hepatoprotective and immunomodulator)
(34) Alcoholic extract of the whole plant, iridoid (Bhandari et al., 1992)
(CNS depressant)
S. nodosa (3, 19, 29, 30) Iridoids and phenolic acid (Paris & Moyse, 1976; Schaunbenger &
(antiinflammatory) Paris, 1977; Vigneau, 1985)
(1, 3, 19, 29, 30) Plant, iridoids and phenolic acids (Paris & Moyse, 1976; Schaunbenger &
(antibacterial) Paris, 1977; Rombouts and Links, 1956;
Swiatek, 1970)
(19) Phenolic acid (hepatoprotective) (Swiatek, 1970)
Infusion, saponin (cardiovascular) (Karimova et al., 1966)
Infusion (inhibited of motor activity) (Karimova et al., 1966)
Plant (diuretic) (Akhmedov et al., 1969; Schaunbenger &
Paris, 1977)
S. ningpoensis (1–10) Roots, hydrophilic extract, iridoids and (Kajimoto et al., 1989; Quian et al., 1991,
phenolic acids (antiinflammatory) 1992; Zhang et al., 1194)
Methanol extract from roots (antipruritic) (Tohda et al., 2000)
Aqueous extract (cardiovascular) (Kajimoto et al., 1989; Ody, 1993)
(33, 38–40) Plant, methanol extract from roots and (Miyazawa et al., 1998; Pinkas et al., 1994;
phenolic acids (antitumoral, cytotoxic and Liu & Wu, 1993)
cytostatic)
S. oldhamii (33) Ethanol extract from roots, phenolic acid (Won Sick Woo, 1963)
(antibacterial)
Plant (antiinflammatory) (Won Sick Woo, 1963)
S. sambucifolia (17–23, 31, 32) Aerial part, phenolic acids (Fernandez et al., 1996)
(antibacterial)
Aqueous extract of the aerial parts (ashes), (Fernandez Arche et al., 1993)
flavonoids and saponins (diuretic)
S. scopolii (9) Phenylpropanoid glycoside (antitumor, (Saracoglu et al., 1997)
cytotoxic and cytostatic)
S. scorodonia (24) Methanol extract from flowers, (Martin et al., 1998; Emam et al., 1997)
Buddlejasaponin I (protozoocidal, fungicidal and
molluscicidal)
(1–3, 24–28) Iridoids, Buddlejasaponin I (Bermejo Benito et al., 1998, 2000)
(antiinflammatory)
Biologically active substances from Scrophularia 49
HO OH
R CH3
O
OH
O
OH
HO
OH
CH2OH
O
OH
HO O
OH
OH
extract from this species can be considered as a potential been reported already that some of these compounds have
mild antiinflammatory agent on an acute inflammation antiinflammatory action (Fernández et al., 1998). These
process, although harpagoside is not considered the princi- authors showed that p-coumaric (17), caffeic (18), ferulic
pal responsible of the antiinflammatory effect (García et al., (19), gentisic (20), protocatechuic (21), syringic (22) and iso-
1996). Probably, other bioactive substances are involved, vanillic (23) acids isolated from S. frutescens are moderate
such as phenolics acids, previously isolated from the aqueous systemic antiinflammatory agents but have a strong anti-
extract of this species (Fernández et al., 1996), since it has inflammatory effect when applied locally at the site of
50 J. de Santos Galíndez et al.
H OR
O
O
CH2OH
O
OH
O
OH
HO
OH
H O
H
R2O
H OR1
OR2
O
R1O O OH
O OH
R3
CH3
HO O
OH
OH
COMPOUND R SPECIES REFERENCES
R1 = caffeoyl
(10) Angoroside C R2 = arabinose S. scopolii (Saracoglu et al., 1997)
R3 = OCH3
OR2
OR1
R3O
H3C O
O O
CH2OH
O
CH2OH
OH O
OH
OH
(11) 6-O-α−α − L-(2″ -O-acetyl-3″ , 4″ -O-di-p-methoxy- R1 = CH3-CO- S. auriculata (Giner et al., 1991)
cinnamoyl-rhamnopyranosyl)-catalpol R2 = R3 = p-CH3O-C6H4-CH = CH-CO-
(12) 6-O-αα− − L-(4″ -O-acetyl 2″ , 3″ -di-p–methoxycinnamoyl)- R1 = R2 = p-CH3O-C6H4-CH = CH-CO- S. auriculata (Giner et al., 1991)
rhamnopyranosyl-catalpol R3 = CH3-CO-
(28) 6-O-αα− − L-(2″ -O-acetyl–3″ , 4″ -di-O-trans-cinnamoyl)- R1 = CH3-CO- S. scorodonia (Bermejo Benito et al., 2000)
rhamnopyranosyl-catalpol (Scropolioside B) R = 2 R3
= C6H5-CH = CH-CO-
inflammation. In the topical model, the best antiinflamma- and ferulic (19) acids, showed good antiinflammatory activ-
tory activity might be afforded by compounds related to ity. Their effect on leukocyte migration to the inflamed site
benzoic acid derivates, compounds with methoxy group sub- might be an important aspect of their mechanism of action.
stitution at C-3 or C-5, or both. After topical administration, It seems that the phenolic acids that are the active principles
the compounds, especially syringic (22), protocatechuic (21) of some orally administered medicinal plants might merely
52 J. de Santos Galíndez et al.
CH=CH-COOH
R3 R1
R2
COOH
R1
R4 R2
R3
act synergistically with other active substances, for example, any significant effect on prostaglandin E2 (PGE2) and
harpagoside (2), isolated from S. frutescens, might be leukotriene C4 (LTC4) released from calcium ionophore-
another bioactive compound involved in its action stimulated mouse peritoneal macrophages. In the PGE2-
(Fernández et al., 1998). release assay, only harpagoside (2) and 8-O-acetyl-harpagide
Buddlejasaponin I (24), a biologically active compound (26) showed an inhibition rate of 30–40%. In the LTC4 assay,
from S. scorodonia L., exerts potent in vivo antiinflammatory only aucuboside (3) showed a significant effect, with a IC50
effects on mouse ear edema induced by phorbol myristate value of 72 mM. Harpagoside (2) and harpagide (1) also
acetate (PMA). The screening for in vitro effects of this inhibited release of LTC4, but it was not a very significant
saikosaponin on cellular systems generating cyclooxygenase effect. However, most iridoids assayed showed a significant
(COX) and lipoxygenase (LOX) metabolites showed a sig- effect on thromboxane B2 (TXB2) release from calcium
nificant effect. These data support the inhibition of arachi- ionophore-stimulated human platelets, with inhibition per-
donic acid metabolism as one of the biochemical centages slightly lower than the reference drug ibuprofen.
mechanisms that might be the rationale for the putative Only harpagide (1), scorodioside (27) and scropolioside B
antiphogistic activity of this saikosaponin (Bermejo Benito (28) had no significant effect on TXB2-release. These results
et al., 1998). indicated that selective inhibition of thromboxane synthase
Seven iridoid glycosides isolated from different extracts enzyme may be the primary target of action of most of these
of S. scorodonia L., namely bartsioside (25), aucuboside (3), iridoids, and one of the mechanisms through which they exert
harpagide (1), harpagoside (2), 8-O-acetylharpagide (26), their antiinflammatory effects. This result does not contra-
scorodioside (27) and scropolioside B (28), have been eval- diction information in the literature, where some authors
uated for their in vitro antiinflammatory activity in cellular found negative results with in vivo models after oral admin-
systems generating cyclooxygenase (COX) and lipoxygenase istration (Lanhers et al., 1992) and other authors obtained
(LOX) metabolites (Bermejo Benito et al., 2000). Iridoids positive results in topical processes (Recio et al., 1994).
did not show a cytotoxic effect even at the higher concen- Further conclusions about iridoid structure-activity relation-
tration of 100 mM. Most compounds assayed did not exhibit ships are that substitutions with an additional moiety at C-8
54 J. de Santos Galíndez et al.
CH3O
CH2OH
R1O CH2OH
(13) Verbascosaponin A R1 = Rha (1→ 4) Glc(1→ 3)[Glc(1→ 2)] Fuc S. auriculata (Giner et al., 2000)
O
CH3 CH2OH
OH
OH O
O
OH O
OH
OH O O
O OH OH
CH3
OH
OH
OH OH
OH
HO O
OH
OH O
is a positive chemical feature for thromboxane-synthase S. nodosa has also been considered to possess antiinflam-
activity [8-O-acetylharpagide (26) and harpagoside (2) matory properties. From this species have been isolated aucu-
versus harpagide (1)]. The presence of a foreign moiety at boside (3), catalpol (29), catalposide (30), ferulic acid (19)
C-6 is unfavourable, as is apparent when the activity of bart- and ester derivatives of harpagide. These compounds could
sioside (25) (iridoid with no hydroxyl substituents in the be responsible of the activity, together with other substances
body of the molecule, and only active on thromboxane syn- (Paris & Moyse, 1976; Schaunbenger & Paris, 1977; Vigneau,
thase) is compared with scorodioside (27) and scropolioside 1985). S. oldhamii has been used traditionally in medicine for
B (28), which are inactive. the treatment of inflammation (Won Sick Woo, 1963).
Biologically active substances from Scrophularia 55
OH
H3C O
R3O
OR1
OR2
Antibacterial
syringic (22), caffeic (18), gentisic (20), protocatechuic (21),
S. nodosa, S. auriculata and S. canina have been used since p-coumaric (17) and vanillic (32) acids]. Therefore, these
the Middle Ages as a remedy for scrophulas and several der- species could be considered as potentially antiseptic agents
matoses (scabies, tumours) (Paris & Moyse, 1976). Also, dif- on bacteriologic infections, especially in processes where
ferent reports have suggested that the antiseptic properties of Gram-positive bacteria are involved (Fernández et al., 1996).
these species could be attributed to the presence of phenolic Methoxycinnamic acid (33), isolated by EtOH extract from
acids (Swiatek, 1970, 1973; Van Hellemont, 1986). At roots of S. oldhamii, showed good antipyretic action. Both
present, S. nodosa is considered by several authors to pos- p-methoxycinnamic (33) and the EtOH extract from S.
sess basteriostatic properties (Schaunbenger & Paris, 1977; oldhamii exhibited good antipyretic activity when tested on
Swiatek, 1970). The following glycosides have been isolated typhoid-vaccinated rabbits (Won Sick Woo, 1963).
from this species: aucuboside (3), catalpol (29), catalposide
(30), ferulic acid (19) and ester derivates of harpagide (1).
Hepatoprotective
The therapeutic properties of the Figwort, S. nodosa, prob-
ably depend of these constituents. For example, aucuboside The alcoholic extract of the aerial parts of S. koelzii sig-
(3) and ferulic acid (19) possess antibacterial properties nificantly protected against thioacetamide-induced hepatic
(Rombouts & Links, 1956; Davini et al., 1986; Fernández damage (Garg et al., 1994). This extract was fractionated
et al., 1998). with different solvents (hexane, chloroform, butanol and
The phenolic fractions of the aerial parts of S. frutescens water). Hepatoprotective activity was localized in the
and S. sambucifolia showed potent antibacterial activity chloroform fraction from which four iridoid glycosides,
(Fernández et al., 1996). However, S. frutescens, the species namely, scropolioside A (15), koelzioside (34), harpagoside
most rich in phenolic acids, demonstrated a more pronunced (2) and 6-O-a-L-(3≤-O-p-methoxycinnamoyl)-rhamnopyra-
activity than S. sambucifolia. The phenolic fractions of both nosyl-catalpol (35), were isolated. Among these, scropolio-
species showed more activity against Gram-positive bacteria, side A (15) showed the greatest hepatoprotective activity.
specifically against Bacillus sp. The higher concentration of The activity of this compound was comparable to that of
the phenolic compounds detected in S. frutescens could silymarin, a clinically used hepatoprotective drug. The
explain the more potent activity of this species. These pre- important observation, however, is that the greatest protec-
liminary results suggest that the antibacterial activity of tion was achieved with the alcoholic extract only. Hence, it
these species can be attributed to the presence of phenolic is likely that the hepatoprotective activity of S. koelzii may
acids [ferulic (19), isovanillic (23), p-hydroxybenzoic (31), not be due to any single constituent. Rather, there may be
56 J. de Santos Galíndez et al.
yet to be discovered; large numbers of plants are constantly Emam AM, Díaz Lanza AM, Matellano Fernández L, Faure R,
being screened for their possible pharmacological value. Moussa AM, et al. (1997): Biological activities of budle-
Some of these plants belong to the Scrophularia genus. This jasaponin isolated from Budleja madagascariensis and
genus may prove to be a richer source of compounds with Scrophularia scorodonia. Pharmazie 52: 76–77.
possible pharmacological values, but more pharmacological Fernández Arche MA, García Jiménez MD, Saenz Rodríguez
investigations are neccesary. MT, De la Puerta Vázquez R (1993): Action de Scrophu-
However, most of the reported biological studies of Scro- laria frutescens L. et Scrophularia sambucifolia subsp.
phularia constituents and extracts were carried out in vitro, sambucifolia maire sur L’excretion renale. Plantes Médici-
although bioactive iridoids found in Scrophularia can often nales et phytotherapie XXVI, Vol. 4: 362–367.
lead to a multiplicity of compounds after in vivo administra- Fernández MA, García MD, Saenz MT (1996): Antibacterial
tion. For this reason more biological and chemical attention activity of the phenolic acids fractions of Scrophularia
is needed. frutescens and Scrophularia sambucifolia. J Ethnopharma-
col 53: 11–14.
Fernández MA, Saenz MT, García MD (1998): Antiinflam-
Acknowledgements matory activity in rats and mice of phenolic acids isolated
from Scrophularia frutescens. J Pharm Pharmacol 50:
This work was supported by: Acciones Integradas España-
1183–1186.
Francia (Rf.HF-211 & 98B) M.E.C. (Ministerio de Edu-
García D, Fernández A, Sáenz T, Ahumada C (1996): Antiin-
cación y Cultura); Ministerio de Sanidad (FISS Rf. 94/1671);
flammatory effects of different extracts and harpagoside
C.A.M. (Comunidad Autonoma de Madrid Rf. C101/91); isolated from Scrophularia frutescens. Il Farmaco 51:
U.A.H. (Ref. EO01/99); A Grant from Consejería de Edu- 443–446.
cación y Cultura de Madrid, Comunidad Autónoma de García MD, Ahumada MC, Saenz MT (1998): Cytostatic activ-
Madrid (Conv. 98). ity of some phenolic acids of Scrophularia frutescens L. var
frutescens. Z Naturforsch 53c: 1093–1095.
Garg HS, Bhandari SPS, Tripmatisis C, Patnaik GK, Puri A, et
References
al. (1994): Antihepatotoxic and immunostimulant proper-
Akhmedov SG, Tkachenko DA, Kharchenko NS (1969): Phar- ties of iridoid glicosides of Scrophularia koelzii. Phy-
macology of flavonoid aglicons of Scrophularia grosheimi. totherapy Res 8: 224–228.
Farmakol Toksikol 32: 693–694. Giner RM, Sanz MJ, Fernández ML, Recio MC, Terencio MC,
Bermejo Benito P, Abad Martínez MJ, Silván Sen AM, Sanz Ríos FJC (1991): Topical antiinflammatory activity of some
Gómez A, Fernández Matellano L, Sánchez Contreras S, iridoids and phenylpropanoids. Planta Med 57: A59.
Díaz Lanza AM (1998): In vivo and in vitro antiinflamma- Giner RM, Villalba ML, Recio MC, Mañez S, Gray AI, Ríos J.L
tory activity of saikosaponins. Life Sci 63: 1147–1156. (1998): A new ridoid from Scrophularia auriculata ssp.
Bermejo Benito P, Díaz Lanza AM, Silván Sen AM, De Santos pseudoauriculata. J Nat Prod 61: 1162–1163.
Galíndez J, Fernández Matellano L, Sanz Gómez A, Abad Giner RM, Villalba ML, Recio MC, Mañez S, Cerdá-Nicolás M,
Martínez MJ (2000): Effects of some iridoids from plant Ríos JL (2000): Anti-inflammatory glycoterpenoids from
origin on arachidonic acid metabolism in cellular systems. Scrophularia auriculata. Eur J Pharmacol 389: 243–
Planta Med 66: 324–328. 252.
Bhandari SPS, Babu UV, Garg HS (1997): A triterpene glyco- Guisalberti EL (1998): Biological and pharmacological activity
side from Scrophularia koelzii. Phytochemistry 45: of naturally occurring iridoids and secoiridoids. Phytomedi-
1717–1719. cine 5: 147–163.
Bhandari SPS, Anil M, Raja R, Garg HS (1992): Koelzioside, Heather M, Henderson MRH (1994): The physicians of
an iridoid diglycoside from Scrophularia koelzii. Phyto- Myddfai: The Welsh herbal tradition. Bot J Scotl 46:
chemistry 31: 689–691. 623–627.
Calis I, Zor M, Basaran A (1993): Karsoside and scropolioside Kajimoto T, Hidaka M, Shoyama K, Nohara T (1989): Iridoids
D, two new iridoid glicosides from Scrophularia ilwensis. from Scrophularia ningpoensis. Phytochemistry 28:
J Nat Prod 56: 606–609. 2701–2704.
Cuéllar MJ, Giner RM, Recio MC, Just MJ, Mañez S, Cerdá M, Karimova SG, Smirnova SG, Nasyrov KM (1966): Chemical
Ríos JL (1998): Screening of anti-inflammatory medicinal composition and pharmacology of the Scrophulariaceae.
plants used in traditional medicine against skin diseases. Mater Konf Tiziol Biokhim Farmakol Uchestiem Prakt
Phytotherapy Res 12: 18–23. Urachei Ufa: 153–155.
Davini E, Iavarone C, Trogolo C, Aureli P, Pasolini B (1986): Kim SR, Kim YC (2000): Neuroprotective phenylpropanoid
The quantitative isolation and antimicrobial activity of the esters of rhamnose isolated from roots of Scrophularia
aglycone of aucubin. Phytochemistry 25: 2420–2422. buergeriana. Phytochemistry 54: 503–509.
De Santos J, Fernández L, Díaz AM, Rubio B, Olivier E, et al. Lacaille-Dubois MA, Wagner H (1996): Importance pharma-
(1998): Catalpol glycosides from Scrophularia scorodonia. cologique des dérivés polyphénoliques. Acta Bot Gallica
Pharmazie 53: 427–428. 143: 555–562.
Biologically active substances from Scrophularia 59
Lanhers MC, Fleuretin J, Mortier F, Vinche A, Younos C (1992): and its glycosides from Scrophularia ningpoensis. Phyto-
Antiinflammatory and analgesic effects of an aqueous chemistry 31: 905–911.
extract of Harpagophytum procumbes. Planta Med 58: Recio MC, Giner RM, Mañez S, Ríos JL (1994): Structural con-
117–123. siderations on the iridoids as antiinflammatory agents.
Liu JQ, Wu DW (1993): 32 cases of postoperative osteogenic Planta Med 60: 232–234.
sarcoma treated by chemotherapy combined with Chinese Rombouts JK, Links J (1956): Nature of the antibacterial sub-
medicinal herbs. Chung Kuo Chung Hsi I Chieh Ho Tsa stances in Aucuba japonica. Experientia 12: 78.
Chih 13: 150–152. Saracoglu I, Calis I, Inoue M, Ogihara Y (1997): Selective cyto-
Martín T, Villaescusa L, Gasquet M, Delmas F, Bartolome C, et toxic and cytostatic activity of some phenylpropanoid gly-
al. (1998): Screening for protozoocidal activity of Spanish cosides. Fitoterapia 68: 434–438.
plants. Pharm Biol 36: 56–62. Schaunbenger P, Paris F (1977): In: Delachaux, Niestle SA,
Miyazawa M, Okuno Y, Nakamura SI, Kameoka H (1998): Sup- Eds., Guide des Plantes Médicinales. Paris, p. 262.
presion of SOS-inducing activity of chemical mutagens by Swiatek L (1970): Pharmacobotanical investigations on some
cinnamic acid derivatives from Scrophularia ningpoensis in species of family Scrophulariaceae. IV. Chemical con-
the Salmonella typhymurium TA1535/psk1002 umu test. J stituents of the herbs of Scrophularia nodosa. Dissert
Agric Food Chem 46: 904–910. Pharm Pharmacol 22: 321–328.
Nishibe S (1994): Bioactive phenolic compounds in traditional Swiatek L (1973): Phenolic acids of underground parts of Scro-
medicines. Pure & Appl Chem 66: 2263–2266. phularia nodosa. Pol J Pharmacol Pharm 25: 461–464.
Ody P (1993): In: Raíces, Ed., Las plantas medicinales, Tohda C, Kakihara Y, Komatsu K, Kuraishi Y (2000): Inhibitory
p. 135. España. effects of methanol extracts of herbal medicines on sub-
Pandey BL, Das PK (1988): Immunopharmacological studies stance P-induced itch-scratch response. Biol Pharm Bull
on Picrorhiza kurroa Part III Adrenergic mechanisms of 23: 599–601.
antiinflammatory action. Indian J Physiol Pharmacol 32: Van Hellemont J (1986): Compedium de Phytotherapie. Paris,
120–125. Servicie Scientifique, p. 371.
Paris RR, Moyse H (1976): In: Masson, Ed., Matiére Vigneau C (1985): In: Masson, Ed., Plantes Médicinales, Paris,
Medicale Vol I, p. 247. Paris. p. 114.
Pauli GF, Ofterdinger-Daegel S, Teborg D (1995): Digitalis, Won Sick Woo (1963): Pharmacologically active component in
Scrophularia & Co. A pharmaceutical survey of Scrophu- Scrophularia root, p-methoxycinnamic acid. I. Identifica-
lariaceae. Dtsch Apoth Ztg 135: 21–34. tion of p-methoxicinnamic acid and its antipiretic action.
Pinkas M, Trotin F, Peng W, Torck M (1994): Use, chemistry Yakhak Hoeiji 7: 55–57.
and pharmacology of ten Chinese medicinal plants. Fitoter- Zhang WY, Yang HJ, Liu YQ, He ZD, Jin YQ, Yang CR (1992):
apia 65: 343–354. Iridodial glycosides from Scrophularia spicata. Acta
Qian J, Hunkler D, Safayhii H, Rimpler H (1991): New iridoid- Botanica Yunnanica 14: 437–441.
related constituents and the antiinflammatory activity of Zhang WJ, Liu YQ, Li XC, Pu XY, Jin JQ, Yang CR (1994):
Scrophularia ningpoensis. Planta Med 57: A56. Chemical constituent from Scrophularia ningpoensis. Acta
Qian J, Hunkler D, Rimpler H (1992): Iridoid-relatedaglicone Botanica Yunnanica 16: 407–412.